Potential Cost-effectiveness of Early Identification of Hospital-acquired Infection in Critically Ill Patients.
Ephraim L TsalikYanhong LiLori L HudsonVivian H ChuTiffany HimmelAlex T LimkakengJason N KatzSeth W GlickmanMicah T McClainKaren E Welty-WolfVance G FowlerGeoffrey S GinsburgChristopher W WoodsShelby D ReedPublished in: Annals of the American Thoracic Society (2016)
Development and use of serial diagnostic testing that reduces the proportion of patients with delays in appropriate antibiotic therapy for hospital-acquired infections could reduce inpatient mortality. The model presented here offers a cost-effectiveness framework for future test development.